Previous close | 200.81 |
Open | 201.73 |
Bid | 80.23 x 1300 |
Ask | 200.65 x 800 |
Day's range | 197.84 - 201.20 |
52-week range | 180.54 - 254.00 |
Volume | |
Avg. volume | 480,812 |
Market cap | 19.714B |
Beta (5Y monthly) | 0.79 |
PE ratio (TTM) | 35.12 |
EPS (TTM) | 5.68 |
Earnings date | 08 May 2024 - 13 May 2024 |
Forward dividend & yield | 2.08 (1.04%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | 241.29 |
STERIS (NYSE:STE) has had a rough month with its share price down 13%. We, however decided to study the company's...
Edwards Lifesciences, DexCom and STERIS have been highlighted in this Industry Outlook article.
The Zacks Medical - Instruments industry is expected to gain from the rising adoption of smart healthcare options, including genAI. However, supply issues and staffing shortages continue to disrupt growth. EW, DXCM and STE appear well-poised to brave the challenges.